Advances in synthetic biology and genome editing have led to a growing industry to develop customized cell lines for medical research. These engineered cell lines, however, can be vulnerable to misidentification, cross-contamination and illegal replication. Custom cell lines are used in the development of vaccines and targeted therapies for a range of diseases. “Companies developing cell lines are making a huge investment. “Companies developing cell lines are making a huge investment,” Bleris said.